|
|
||||||||




*
Immunobiology Unit, Institute of Child Health, London;
Medical Research Council Immunochemistry Unit, Oxford; and
Medical Microbiology, Imperial College School of Medicine, St. Marys Hospital, London, United Kingdom; and
§
Institute for Hygiene and Microbiology, Würzburg, Germany
Mannose-binding lectin (MBL) is a serum protein that has been demonstrated to activate the classical complement pathway and to function directly as an opsonin. Although MBL deficiency is associated with a common opsonic defect and a predisposition to infection, the role of the protein in bacterial infection remains unclear. We have investigated MBL binding to Neisseria meningitidis serogroup B1940 and three isogenic mutants, and the subsequent activation of the two major isoforms of C4 (C4A and C4B) by an associated serine protease, MASP. The mutants lacked expression of the capsular polysaccharide (siaD-), the lipo-oligosaccharide (LOS) outer core that prevented LOS sialylation (cpsD-), or both capsule and LOS outer core (cps-). Using flow cytometry, it was possible to detect strong MBL binding to the cps- and cpsD- mutants over a wide range of concentrations. In contrast, minimal or no MBL binding was detected on the parent organism, with binding to siaD- only at higher MBL concentrations. C4 was activated and bound by mutants that had previously bound MBL/MASP, but there was no significant difference in the amounts of C4A and C4B bound. When sialic acid residues were removed from the parent organism by neuraminidase treatment, the binding of both MBL and C4 increased significantly. Our results suggest that MBL may bind to and activate complement on these encapsulated organisms, and the major determinants of these effects are the LOS structure and sialylation.
This article has been cited by other articles:
![]() |
R. M. J. Hamvas, M. Johnson, A. M. Vlieger, C. Ling, A. Sherriff, A. Wade, N. J. Klein, M. W. Turner, The ALSPAC Study Team, and A. D. B. Webster Role for Mannose Binding Lectin in the Prevention of Mycoplasma Infection Infect. Immun., August 1, 2005; 73(8): 5238 - 5240. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jarva, S. Ram, U. Vogel, A. M. Blom, and S. Meri Binding of the Complement Inhibitor C4bp to Serogroup B Neisseria meningitidis J. Immunol., May 15, 2005; 174(10): 6299 - 6307. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Jack, M. E. Lee, M. W. Turner, N. J. Klein, and R. C. Read Mannose-binding lectin enhances phagocytosis and killing of Neisseria meningitidis by human macrophages J. Leukoc. Biol., March 1, 2005; 77(3): 328 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Lairson, C. P. C. Chiu, H. D. Ly, S. He, W. W. Wakarchuk, N. C. J. Strynadka, and S. G. Withers Intermediate Trapping on a Mutant Retaining {alpha}-Galactosyltransferase Identifies an Unexpected Aspartate Residue J. Biol. Chem., July 2, 2004; 279(27): 28339 - 28344. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Estabrook, D. L. Jack, N. J. Klein, and G. A. Jarvis Mannose-Binding Lectin Binds to Two Major Outer Membrane Proteins, Opacity Protein and Porin, of Neisseria meningitidis J. Immunol., March 15, 2004; 172(6): 3784 - 3792. [Abstract] [Full Text] [PDF] |
||||
![]() |
A J Kvalsvig and D J Unsworth The immunopathogenesis of meningococcal disease J. Clin. Pathol., June 1, 2003; 56(6): 417 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jaatinen, M. Lahti, O. Ruuskanen, R. Kinos, L. Truedsson, R. Lahesmaa, and M.-L. Lokki Total C4B Deficiency Due to Gene Deletion and Gene Conversion in a Patient with Severe Infections Clin. Vaccine Immunol., March 1, 2003; 10(2): 195 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gulati, K. Sastry, J. C. Jensenius, P. A. Rice, and S. Ram Regulation of the Mannan-Binding Lectin Pathway of Complement on Neisseria gonorrhoeae by C1-Inhibitor and {alpha}2-Macroglobulin J. Immunol., April 15, 2002; 168(8): 4078 - 4086. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Brandtzaeg, A. Bjerre, R. Ovstebo, B. Brusletto, G. B. Joo, and P. Kierulf Invited review: Neisseria meningitidis lipopolysaccharides in human pathology Innate Immunity, December 1, 2001; 7(6): 401 - 420. [Abstract] [PDF] |
||||
![]() |
C. M. Fernandez-Prada, M. Nikolich, R. Vemulapalli, N. Sriranganathan, S. M. Boyle, G. G. Schurig, T. L. Hadfield, and D. L. Hoover Deletion of wboA Enhances Activation of the Lectin Pathway of Complement in Brucella abortus and Brucella melitensis Infect. Immun., July 1, 2001; 69(7): 4407 - 4416. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Thielens, S. Cseh, S. Thiel, T. Vorup-Jensen, V. Rossi, J. C. Jensenius, and G. J. Arlaud Interaction Properties of Human Mannan-Binding Lectin (MBL)-Associated Serine Proteases-1 and -2, MBL-Associated Protein 19, and MBL J. Immunol., April 15, 2001; 166(8): 5068 - 5077. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Taraktchoglou, A. A. Pacey, J. E. Turnbull, and A. Eley Infectivity of Chlamydia trachomatis Serovar LGV but Not E Is Dependent on Host Cell Heparan Sulfate Infect. Immun., February 1, 2001; 69(2): 968 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Devyatyarova-Johnson, I. H. Rees, B. D. Robertson, M. W. Turner, N. J. Klein, and D. L. Jack The Lipopolysaccharide Structures of Salmonella enterica Serovar Typhimurium and Neisseria gonorrhoeae Determine the Attachment of Human Mannose-Binding Lectin to Intact Organisms Infect. Immun., July 1, 2000; 68(7): 3894 - 3899. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Neth, D. L. Jack, A. W. Dodds, H. Holzel, N. J. Klein, and M. W. Turner Mannose-Binding Lectin Binds to a Range of Clinically Relevant Microorganisms and Promotes Complement Deposition Infect. Immun., February 1, 2000; 68(2): 688 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Stover, S. Thiel, N. J. Lynch, and W. J. Schwaeble The Rat and Mouse Homologues of MASP-2 and MAp19, components of the Lectin Activation Pathway of Complement J. Immunol., December 15, 1999; 163(12): 6848 - 6859. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |